Delivery route considerations for designing antigen-specific biomaterial strategies to combat autoimmunity.


Journal

Advanced nanobiomed research
ISSN: 2699-9307
Titre abrégé: Adv Nanobiomed Res
Pays: Germany
ID NLM: 101773117

Informations de publication

Date de publication:
Mar 2023
Historique:
pmc-release: 01 03 2024
entrez: 20 3 2023
pubmed: 21 3 2023
medline: 21 3 2023
Statut: ppublish

Résumé

Disease modifying drugs and biologics used to treat autoimmune diseases, although promising, are non-curative. As the field moves towards development of new approaches to treat autoimmune disease, antigen-specific therapies immunotherapies (ASITs) have emerged. Despite clinical approval of ASITs for allergies, clinical trials using soluble ASITs for autoimmunity have been largely unsuccessful. A major effort to address this shortcoming is the use of biomaterials to harness the features unique to specific delivery routes. This review focuses on biomaterials being developed for delivery route-specific strategies to induce antigen-specific responses in autoimmune diseases such as multiple sclerosis, type 1 diabetes, rheumatoid arthritis, and celiac disease. We first discuss the delivery strategies used in ongoing and completed clinical trials in autoimmune ASITs. Next, we highlight pre-clinical biomaterial approaches from the most recent 3 years in the context of these same delivery route considerations. Lastly, we provide discussion on the gaps remaining in biomaterials development and comment on the need to consider delivery routes in the process of designing biomaterials for ASITs.

Identifiants

pubmed: 36938103
doi: 10.1002/anbr.202200135
pmc: PMC10019031
mid: NIHMS1873059
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : BLRD VA
ID : I01 BX003690
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI144667
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI169686
Pays : United States
Organisme : NIBIB NIH HHS
ID : R01 EB027143
Pays : United States

Déclaration de conflit d'intérêts

Conflicts of interest CMJ is an employee of the VA Maryland Health Care System. The views reported here do not reflect the views of the VA or United States Government. CMJ has an equity position with Vaccitech plc. Beyond these declarations, there are no other conflicts of interests to report. The review was conducted in the absence of any commercial or financial relationships.

Références

Neurology. 2011 Oct 18;77(16):1551-60
pubmed: 21975206
Science. 1993 Feb 26;259(5099):1321-4
pubmed: 7680493
RMD Open. 2015 Jun 29;1(1):e000012
pubmed: 26509048
Biomaterials. 2017 Oct;143:79-92
pubmed: 28772190
Adv Healthc Mater. 2017 Mar;6(6):
pubmed: 28116870
J Vis Exp. 2014 Jan 02;(83):e50984
pubmed: 24430972
Immunol Cell Biol. 2022 Jan;100(1):33-48
pubmed: 34668580
Front Immunol. 2022 Mar 14;13:843355
pubmed: 35359943
N Engl J Med. 2017 Feb 16;376(7):697-699
pubmed: 28199812
Am J Pathol. 2008 Sep;173(3):600-9
pubmed: 18688037
Nano Lett. 2021 May 12;21(9):3762-3771
pubmed: 33881872
Proc Natl Acad Sci U S A. 2022 Jun 14;119(24):e2202069119
pubmed: 35679343
J Neurol Sci. 1997 Nov 6;152(1):31-8
pubmed: 9395124
Sci Rep. 2020 Nov 3;10(1):18927
pubmed: 33144616
Ann Neurol. 2000 Nov;48(5):758-65
pubmed: 11079539
Nat Biotechnol. 2015 Sep;33(9):941-51
pubmed: 26348965
Bioconjug Chem. 2018 Mar 21;29(3):813-823
pubmed: 29148731
Cell Rep. 2020 Mar 24;30(12):3964-3971.e7
pubmed: 32209459
ACS Biomater Sci Eng. 2019 May 13;5(5):2631-2646
pubmed: 31119191
ACS Nano. 2021 Mar 23;15(3):4305-4320
pubmed: 33645967
Arthritis Rheum. 1998 Feb;41(2):290-7
pubmed: 9485087
Nat Genet. 2018 May;50(5):699-707
pubmed: 29662164
Curr Opin Endocrinol Diabetes Obes. 2021 Aug 1;28(4):411-418
pubmed: 34101651
Nat Rev Immunol. 2019 Jan;19(1):19-30
pubmed: 30429578
Mol Pharm. 2020 Sep 8;17(9):3513-3525
pubmed: 32787283
JAMA Neurol. 2013 Sep 1;70(9):1105-9
pubmed: 23817921
Lancet Diabetes Endocrinol. 2020 Jun;8(6):470-472
pubmed: 32723484
Autoimmun Rev. 2019 Jun;18(6):607-614
pubmed: 30959217
Adv Funct Mater. 2017 Jun 13;27(22):
pubmed: 29503604
Science. 1993 Sep 24;261(5129):1727-30
pubmed: 8378772
Front Immunol. 2021 Jan 18;11:603029
pubmed: 33537031
Science. 2022 Jan 21;375(6578):296-301
pubmed: 35025605
J Autoimmun. 2014 Nov;54:33-50
pubmed: 25175979
Nanomedicine. 2017 Jan;13(1):191-200
pubmed: 27720992
Nat Med. 2000 Oct;6(10):1167-75
pubmed: 11017150
ACS Appl Bio Mater. 2019 Jun 17;2(6):2388-2404
pubmed: 35030696
Sci Adv. 2020 Oct 16;6(42):
pubmed: 33067238
Adv Mater. 2020 Apr;32(13):e1903367
pubmed: 31782844
Gastroenterology. 2020 May;158(6):1667-1681.e12
pubmed: 32032584
Sci Transl Med. 2021 Mar 10;13(584):
pubmed: 33692135
Neurology. 2000 Apr 11;54(7):1414-20
pubmed: 10751249
Immunotherapy. 2013 Sep;5(9):955-74
pubmed: 23998731
Curr Rheumatol Rep. 2001 Feb;3(1):64-9
pubmed: 11177772
Nature. 2016 Jun 01;534(7607):396-401
pubmed: 27281205
Arthritis Rheum. 2009 Nov;60(11):3207-16
pubmed: 19877047
Nat Med. 2005 Apr;11(4 Suppl):S45-53
pubmed: 15812489
Adv Healthc Mater. 2018 Sep;7(18):e1800341
pubmed: 30051618
Lab Anim Res. 2021 Aug 24;37(1):23
pubmed: 34429169
J Pharm Sci. 2017 Nov;106(11):3293-3302
pubmed: 28625726
Proc Natl Acad Sci U S A. 2020 Dec 15;117(50):32017-32028
pubmed: 33239445
Diabetes Care. 2004 Oct;27(10):2348-55
pubmed: 15451899
Mol Pharm. 2021 Apr 5;18(4):1806-1818
pubmed: 33734705
Gastroenterology. 2021 Jul;161(1):66-80.e8
pubmed: 33722583
Eur J Immunol. 2022 Jan;52(1):24-33
pubmed: 34727577
Arthritis Res Ther. 2009;11(6):R180
pubmed: 19951408
Front Immunol. 2017 Apr 18;8:425
pubmed: 28458668
Diabetes. 2021 Aug 13;:
pubmed: 34957480
Polymers (Basel). 2020 Dec 21;12(12):
pubmed: 33371329
Mol Pharm. 2019 Feb 4;16(2):607-617
pubmed: 30615457
Brain Sci. 2020 May 29;10(6):
pubmed: 32486045
Dev Med Child Neurol. 2005 Nov;47(11):785-91
pubmed: 16225745
Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):15745-50
pubmed: 21896725
Lupus. 2006;15(11):737-45
pubmed: 17153844
Ann Neurol. 2008 May;63(5):611-20
pubmed: 18481290
Biomaterials. 2021 Oct;277:121079
pubmed: 34454372
JAMA. 2015 Apr 21;313(15):1541-9
pubmed: 25898052
Curr Opin Organ Transplant. 2018 Feb;23(1):73-82
pubmed: 29189412
ACS Chem Biol. 2021 Oct 15;16(10):1985-1993
pubmed: 34037371
N Engl J Med. 2002 May 30;346(22):1685-91
pubmed: 12037147
Sci Rep. 2017 Apr 20;7:46468
pubmed: 28425447
Arch Neurol. 2007 Oct;64(10):1407-15
pubmed: 17698695
Cell Rep. 2016 Sep 13;16(11):2940-2952
pubmed: 27626664
Clin Dev Immunol. 2013;2013:535738
pubmed: 24062777
Hum Vaccin Immunother. 2015;11(4):991-7
pubmed: 25745830
J Pharm Sci. 2022 Jul;111(7):2072-2082
pubmed: 35108564
Front Immunol. 2019 Feb 19;10:203
pubmed: 30837986
Neurology. 2018 Mar 13;90(11):e955-e962
pubmed: 29467307
Mol Ther. 2017 Dec 6;25(12):2635-2647
pubmed: 28958578
JAMA. 2017 Aug 15;318(7):647-656
pubmed: 28810029
Eur J Neurol. 2006 Aug;13(8):887-95
pubmed: 16879301
World Allergy Organ J. 2015 Mar 07;8(1):9
pubmed: 25780493
BMJ Open. 2019 Jun 28;9(6):e028578
pubmed: 31256036
J Control Release. 2017 Nov 28;266:156-165
pubmed: 28963036
Eur J Immunol. 2005 Feb;35(2):568-74
pubmed: 15682446
Ann Neurol. 2010 Nov;68(5):593-601
pubmed: 21031576
J Autoimmun. 2010 Jun;34(4):408-15
pubmed: 19931408
Clin Microbiol Rev. 2014 Apr;27(2):264-301
pubmed: 24696436
ACS Biomater Sci Eng. 2020 Oct 12;6(10):5941-5958
pubmed: 33320581
Int J Pharm. 2019 May 1;562:303-312
pubmed: 30910633
Curr Top Microbiol Immunol. 2011;352:71-84
pubmed: 21725898
J Neurosci Res. 2018 Jun;96(6):1021-1042
pubmed: 29446144
Autoimmun Rev. 2014 Sep;13(9):981-1000
pubmed: 25092612
Front Immunol. 2018 Mar 02;9:281
pubmed: 29552007
Int J Nanomedicine. 2019 Jul 12;14:5229-5242
pubmed: 31371958
Front Immunol. 2017 Nov 13;8:1539
pubmed: 29181005
Proc Natl Acad Sci U S A. 2019 Apr 23;116(17):8463-8470
pubmed: 30962374
J Immunol. 2019 Jul 1;203(1):48-57
pubmed: 31109955
Ther Deliv. 2017 Jul;8(8):647-661
pubmed: 28730933
J Hum Genet. 2015 Nov;60(11):657-64
pubmed: 26223182
J Control Release. 2006 May 1;112(1):26-34
pubmed: 16529839
JCI Insight. 2019 Sep 19;4(18):
pubmed: 31487265
Ther Adv Vaccines Immunother. 2021 Aug 21;9:25151355211039073
pubmed: 34447901
DNA Cell Biol. 2003 Apr;22(4):227-32
pubmed: 12823899
Front Immunol. 2021 Mar 08;12:586220
pubmed: 33763059
Am Fam Physician. 2011 Dec 1;84(11):1245-52
pubmed: 22150658
Sci Rep. 2021 Sep 8;11(1):17853
pubmed: 34497305
J Clin Invest. 2020 Apr 1;130(4):1823-1829
pubmed: 32125290
Biomaterials. 2019 Nov;222:119440
pubmed: 31450159
Diabetologia. 2018 Jun;61(6):1384-1396
pubmed: 29546475
J Control Release. 2020 Jun 10;322:593-601
pubmed: 32087298
J Autoimmun. 2018 May;89:112-124
pubmed: 29258717
Lancet. 2008 Nov 15;372(9651):1746-55
pubmed: 18814906
World J Hepatol. 2014 Apr 27;6(4):160-8
pubmed: 24799984
Biomaterials. 2019 Nov;222:119432
pubmed: 31480002
Nat Med. 2000 Oct;6(10):1176-82
pubmed: 11017151
Front Immunol. 2021 Oct 14;12:748679
pubmed: 34721418
Nano Res. 2019 Apr;12(4):837-844
pubmed: 33343832
Int J Nanomedicine. 2018 Jun 27;13:3731-3750
pubmed: 29983566
Mol Ther. 2017 Jul 5;25(7):1676-1685
pubmed: 28408181
ACS Nano. 2012 Jun 26;6(6):4947-54
pubmed: 22646927
Maedica (Bucur). 2010 Apr;5(2):132-4
pubmed: 21977137
Front Immunol. 2021 Feb 19;12:624685
pubmed: 33679769
Annu Rev Immunol. 2009;27:363-91
pubmed: 19302045
Diabetes. 2010 Sep;59(9):2087-93
pubmed: 20805382
J Autoimmun. 2010 May;34(3):J258-65
pubmed: 20042314
Biomaterials. 2017 Feb;118:51-62
pubmed: 27940382
Mol Ther. 2017 Jul 5;25(7):1655-1664
pubmed: 28479234
Arthritis Rheum. 1999 Jun;42(6):1204-8
pubmed: 10366113
Diabetes Care. 2021 Jul;44(7):1604-1612
pubmed: 34021020
Science. 2021 Jan 8;371(6525):145-153
pubmed: 33414215
Proc Natl Acad Sci U S A. 2017 Oct 10;114(41):10954-10959
pubmed: 28874533
J Control Release. 2021 Mar 10;331:164-175
pubmed: 33450320
Sci Transl Med. 2015 Jun 3;7(290):290ra87
pubmed: 26041704
Diabetes. 2018 Sep;67(9):1816-1829
pubmed: 29967002
Nanomedicine. 2021 Feb;32:102321
pubmed: 33184020
Nat Nanotechnol. 2017 Jul;12(7):701-710
pubmed: 28436959
Arthritis Rheum. 1996 Jan;39(1):41-51
pubmed: 8546737
Curr Opin Immunol. 2010 Oct;22(5):609-15
pubmed: 20850958
Int J Pharm. 2020 Aug 30;586:119590
pubmed: 32621946
Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3299-303
pubmed: 11248073
Autoimmune Dis. 2014;2014:798029
pubmed: 25610638
Trends Biotechnol. 2018 Jul;36(7):686-699
pubmed: 29588069
Pharmaceutics. 2021 Nov 17;13(11):
pubmed: 34834364
Cell. 2022 Mar 3;185(5):896-915.e19
pubmed: 35180381

Auteurs

Marian A Ackun-Farmmer (MA)

Fischell Department of Bioengineering, University of Maryland, College Park, MD, 20742, USA.

Christopher M Jewell (CM)

Fischell Department of Bioengineering, University of Maryland, College Park, MD, 20742, USA.
US Department of Veterans Affairs, VA Maryland Health Care System, Baltimore, MD, 21201, USA.
Robert E. Fischell Institute for Biomedical Devices, College Park, MD, 20742, USA.
Department of Microbiology and Immunology, University of Maryland Medical School, Baltimore, MD, 21201, USA.
Marlene and Stewart Greenebaum Cancer Center, Baltimore, MD, 21201, USA.

Classifications MeSH